(4'-Fluoro[1,1'-biphenyl]-2-yl)methanamine, 95.0%, 500mg

1-(4-Chlorobenzyl)piperidin-4-amine dihydrochloride, 95.0%, 1g

ETHYL 4-(2,6-DIFLUOROPHENYL)-2-HYDROXY-4-OXOBUT-2-ENOATE, 95.0%, 1g

tert-Butyl (S)-2-(2,6-Dichlorophenyl)-5-oxo-3-[(S)-1-phenylethyl]imidazolidine-1-carboxylate>98.0%(HPLC)(N)1g

[4-(Tetrahydropyran-4-yloxy)phenyl]methanol, 95+%, 500mg

4-Chloro-1H-benzimidazol-5-ol, 95.0%, 5g

tert-Butyl 2-oxo-7-azabicyclo[2.2.1]heptane-7-carboxylate, 95.0%, 5g

4-(1h-Imidazol-1-yl)pyridine, 95%, 50mg

Hidrato de clorhidrato de naranja de acridina, (CI 46005) para microscopía, 5 g, envase de vidrio

2-(4-Bromophenyl)-1-(2,4-dihydroxyphenyl)ethanone, 95.0%, 500mg

6-Oxabicyclo[3.2.1]oct-3-en-7-one, 95.0%, 250mg

2-Bromo-1-methylpyridin-1-ium iodide, 10mg

1-Phenylcyclopropan-1-ol, 98+%, 100mg